Amniotic membrane is an avascular layer of fetal membrane which can be extracted from placenta and stored in a sterile environment right after collection. It can be efficiently used in surgical procedures and in the treatment of ocular diseases or disorders such as ligneous conjunctivitis, corneal disease, etc. as well as for treating tissue damage. An amniotic membrane transplant (AMT) can be done using traditional suture and fibrin glue approach or by an advanced suture-less approach as well. AMT can be used to protect damaged tissues, stimulate growth of new cells, and reduce inflammation and pain by decreasing friction in the eyelids. According to a study published by the National Center for Biotechnology Information (NCBI) in February 2021, 94.3% of people who had undergone amniotic membrane transplant reported of healed epithelial defects while 88% people reported symptomatic relief from symptoms such as dryness, discomfort and pain.
Market Dynamics
Market players are focused on research and development activities to obtain approvals for novel products or techniques associated with amniotic membrane, this could contribute to the growth of the market over the forecast period. For instance, in 2018, MiMedx, an American biomedical company received the status of Regenerative Medicine Advanced Therapy (RMAT) by the U.S. Food and Administration for its product AmnioFix, an amniotic membrane that is designed for use in osteoarthritis treatment.
Market players are focusing on product launches, which is expected to strengthen their position in the global market. For instance, on February, 2020, Integra LifeSciences, an American medical technology company launched AmnioExcel Plus amniotic membrane that helps in wound care.
Market players are involved in expanding their global presence by adopting strategies such as acquisitions and partnerships, this is expected to drive the growth of the amniotic membrane market globally. For instance, in 2017, Organogenesis Holdings Inc., an American regenerative medicine company acquired NuTech Medical, an American biologics company, to expand their company product portfolio and support the development of next generation amniotic membrane products.
Key features of the study:
- This report provides an in-depth analysis of global amniotic membrane market, provides market size (US$ Million), and compound annual growth rate (CAGR %) for the forecast period (2021-2028), considering 2020 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrix for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, regional outlook, and competitive strategies adopted by the leading players
- It profiles leading players in the global amniotic membrane market based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments and strategies, and future plans
- Key companies covered as a part of this study include Smith & Nephew, Applied Biologics, Organogenesis Holdings Inc., Osiris Therapeutics, Inc., Alliqua BioMedical, Inc., Amnio Technology, LLC, Next Biosciences, Integra LifeSciences, MiMedx, LifeCell International, Human Regenerative Technologies, LLC, Amniox Medical, Inc, Skye Biologics Inc., Wright Medical, TissueTech, Katena Products, Inc., NuVision Biotherapies, Surgenex, and Ventris Medical
- Insights from this report would allow marketers and the management authorities of the companies to make informed decision regarding their future product launch, technology up-gradation, market expansion, and marketing tactics
- The global amniotic membrane market report caters to various stakeholders in this industry including investors, suppliers, manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision making through various strategy matrices used in analyzing the amniotic membrane market
Detailed Segmentation:
- Global Amniotic Membrane Market, By Product Type:
- Amniotic Membranes
- Cryopreserved Amniotic Membranes
- Dehydrated Amniotic Membranes
- Amniotic Suspensions
- Global Amniotic Membrane Market, By Application:
- Wound Care
- Orthopedics
- Ophthalmology
- Others
- Global Amniotic Membrane Market, By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research and Academic Institutes
- Global Amniotic Membrane Market, By Region:
- North America
- By Product Type:
- Amniotic Membranes
- Cryopreserved Amniotic Membranes
- Dehydrated Amniotic Membranes
- Amniotic Suspensions
- By Application:
- Wound Care
- Orthopedics
- Ophthalmology
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research and Academic Institutes
- By Country:
- Latin America
- By Product Type:
- Amniotic Membranes
- Cryopreserved Amniotic Membranes
- Dehydrated Amniotic Membranes
- Amniotic Suspensions
- By Application:
- Wound Care
- Orthopedics
- Ophthalmology
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research and Academic Institutes
- By Country:
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Europe
- By Product Type:
- Amniotic Membranes
- Cryopreserved Amniotic Membranes
- Dehydrated Amniotic Membranes
- Amniotic Suspensions
- By Application:
- Wound Care
- Orthopedics
- Ophthalmology
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research and Academic Institutes
- By Country:
- U.K.
- Germany
- Italy
- Spain
- France
- Russia
- Rest of Europe
- Asia Pacific
- By Product Type:
- Amniotic Membranes
- Cryopreserved Amniotic Membranes
- Dehydrated Amniotic Membranes
- Amniotic Suspensions
- By Application:
- Wound Care
- Orthopedics
- Ophthalmology
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research and Academic Institutes
- By Country
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- By Product Type:
- Amniotic Membranes
- Cryopreserved Amniotic Membranes
- Dehydrated Amniotic Membranes
- Amniotic Suspensions
- By Application:
- Wound Care
- Orthopedics
- Ophthalmology
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research and Academic Institutes
- By Country:
- GCC
- Israel
- Rest of Middle East
- Africa
- By Product Type:
- Amniotic Membranes
- Cryopreserved Amniotic Membranes
- Dehydrated Amniotic Membranes
- Amniotic Suspensions
- By Application:
- Wound Care
- Orthopedics
- Ophthalmology
- Others
- By End User:
- Hospitals
- Ambulatory Surgical Centers
- Specialty Clinics
- Research and Academic Institutes
- By Country/Region:
- South Africa
- Central Africa
- North Africa
- Company Profiles
- Smith & Nephew*
- Company Overview
- Product Portfolio
- Financial Performance
- Recent Developments/Updates
- Strategies
- Applied Biologics
- Organogenesis Holdings Inc.
- Osiris Therapeutics, Inc.
- Alliqua BioMedical, Inc.
- Amnio Technology, LLC
- Next Biosciences
- Integra LifeSciences
- MiMedx
- LifeCell International
- Human Regenerative Technologies, LLC
- Amniox Medical, Inc.
- Skye Biologics Inc.
- Wright Medical
- TissueTech
- Katena Products, Inc.
- NuVision Biotherapies
- Surgenex
- Ventris Medical
“*” marked represents similar segmentation in other categories in the respective section.
